Next Article in Journal
Autism and Intellectual Disability Associated with Mitochondrial Disease and Hyperlactacidemia
Next Article in Special Issue
Tumor Progression Locus 2 (Tpl2) Kinase as a Novel Therapeutic Target for Cancer: Double-Sided Effects of Tpl2 on Cancer
Previous Article in Journal
Fatty Acid Signaling: The New Function of Intracellular Lipases
Previous Article in Special Issue
Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
 
 
Search for Articles:
Title / Keyword
Author / Affiliation
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 16
Issue 2
10.3390/ijms16023856
ijms-logo
Submit to this Journal Review for this Journal Edit a Special Issue
► Article Menu

Article Menu

share announcement question_answer thumb_up
...
textsms
...
Article

Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical Prostatectomy

by
Chinyere Ibeawuchi
1,
Hartmut Schmidt
2,
Reinhard Voss
3,
Ulf Titze
4,
Mahmoud Abbas
5,
Joerg Neumann
6,
Elke Eltze
7,
Agnes Marije Hoogland
8,
Guido Jenster
9,
Burkhard Brandt
10 and
Axel Semjonow
1,*
1
Prostate Center, Department of Urology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Gebaeude 1A, Muenster D-48149, Germany
2
Center for Laboratory Medicine, University Hospital Muenster, Albert-Schweitzer-Campus 1, Gebaeude 1A, Muenster D-48149, Germany
3
Interdisciplinary Center for Clinical Research, University of Muenster, Albert-Schweitzer-Campus 1, Gebaeude D3, Domagkstrasse 3, Muenster D-48149, Germany
4
Pathology, Lippe Hospital Detmold, Röntgenstrasse 18, Detmold D-32756, Germany
5
Institute of Pathology, Mathias-Spital-Rheine, Frankenburg Street 31, Rheine D-48431, Germany
6
Institute of Pathology, Klinikum Osnabrueck, Am Finkenhuegel 1, Osnabrueck D-49076, Germany
7
Institute of Pathology, Saarbrücken-Rastpfuhl, Rheinstrasse 2, Saarbrücken D-66113, Germany
8
Department of Pathology, Erasmus Medical Center, 's-Gravendijkwal 230, 3015-CE Rotterdam, The Netherlands
9
Department of Urology, Erasmus Medical Center, 's-Gravendijkwal 230, 3015-CE Rotterdam, The Netherlands
10
Institute for Clinical Chemistry, University Clinic Schleswig-Holsteins, Arnold-Heller-Strasse 3, Haus 17, Kiel D-24105, Germany
*
Author to whom correspondence should be addressed.
Academic Editor: William Cho
Int. J. Mol. Sci. 2015, 16(2), 3856-3869; https://doi.org/10.3390/ijms16023856
Received: 18 December 2014 / Accepted: 5 February 2015 / Published: 11 February 2015
(This article belongs to the Special Issue Advances in Molecular Oncology 2014)
View Full-Text Download PDF
Browse Figures

Abstract

The multifocal nature of prostate cancer (PCa) creates a challenge to patients’ outcome prediction and their clinical management. An approach that scrutinizes every cancer focus is needed in order to generate a comprehensive evaluation of the disease, and by correlating to patients’ clinico-pathological information, specific prognostic biomarker can be identified. Our study utilized the Affymetrix SNP 6.0 Genome-wide assay to investigate forty-three fresh frozen PCa tissue foci from twenty-three patients. With a long clinical follow-up period that ranged from 2.0–9.7 (mean 5.4) years, copy number variation (CNV) data was evaluated for association with patients’ PSA status during follow-up. From our results, the loss of unique genes on 10q23.31 and 10q23.2–10q23.31 were identified to be significantly associated to PSA recurrence (p < 0.05). The implication of PTEN and FAS loss (10q23.31) support previous reports due to their critical roles in prostate carcinogenesis. Furthermore, we hypothesize that the PAPSS2 gene (10q23.2–10q23.31) may be functionally relevant in post-operative PSA recurrence because of its reported role in androgen biosynthesis. It is suggestive that the loss of the susceptible region on chromosome 10q, which implicates PTEN, FAS and PAPSS2 may serve as genetic predictors of PSA recurrence after radical prostatectomy. View Full-Text
Keywords: prostate cancer; PTEN; PAPSS2; copy number variation; PSA recurrence; Affymetrix prostate cancer; PTEN; PAPSS2; copy number variation; PSA recurrence; Affymetrix
►▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

SciFeed

Share and Cite

MDPI and ACS Style

Ibeawuchi, C.; Schmidt, H.; Voss, R.; Titze, U.; Abbas, M.; Neumann, J.; Eltze, E.; Hoogland, A.M.; Jenster, G.; Brandt, B.; Semjonow, A. Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical Prostatectomy. Int. J. Mol. Sci. 2015, 16, 3856-3869. https://doi.org/10.3390/ijms16023856

AMA Style

Ibeawuchi C, Schmidt H, Voss R, Titze U, Abbas M, Neumann J, Eltze E, Hoogland AM, Jenster G, Brandt B, Semjonow A. Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical Prostatectomy. International Journal of Molecular Sciences. 2015; 16(2):3856-3869. https://doi.org/10.3390/ijms16023856

Chicago/Turabian Style

Ibeawuchi, Chinyere, Hartmut Schmidt, Reinhard Voss, Ulf Titze, Mahmoud Abbas, Joerg Neumann, Elke Eltze, Agnes Marije Hoogland, Guido Jenster, Burkhard Brandt, and Axel Semjonow. 2015. "Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical Prostatectomy" International Journal of Molecular Sciences 16, no. 2: 3856-3869. https://doi.org/10.3390/ijms16023856

Find Other Styles

Article Metrics

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop